A clinical trial studying convalescent plasma in COVID patients was determined ineffective by the National Institutes of Health and others.
Tag: clinical trials
A cancer treatment that tackles heart disease?
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
Running clinical trials in a pandemic
Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.
What COVID-19 has taught us about clinical trials
Stanford Medicine researcher John Ioannidis calls for transparency and the sharing of data, a lesson learned through COVID-19.
Nation’s pediatricians push for safe, effective COVID-19 vaccines
Stanford infectious disease expert Yvonne Maldonado, MD, describes principles for developing safe and effective COVID-19 vaccines for everyone.
Many early COVID-19 studies have low-quality design, risk low-value evidence, research finds
Many early clinical studies of COVID-19 fail to meet quality standards, raising concerns that the data could be of little meaningful use, research finds.
Medical device safety in the real world: Tapping EHR data
Researchers at Stanford are mining millions of de-identified patient records using machine learning to determine long-term safety of medical devices.
Move quickly but safely: A view from inside the FDA
At a recent talk on campus, Amy Abernethy, an FDA principal deputy commissioner, discussed her career and her work to facilitate clinical advances.
Autism therapy given by parents and professionals can motivate kids to speak, Stanford study finds
A new Stanford study in children with autism showed the value of teaching parents how to use everyday interactions to motivate their children to speak.
Antibody treatment delays start of Type 1 diabetes by two years
A therapy delayed the onset of Type 1 diabetes in at-risk people by about two years, new results from a clinical trial show.
Anti-CD47 antibody trial in advanced cancers shows treatment appears safe, well-tolerated
An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
Preventing osteoarthritis, an orthopaedic surgeon’s goal
Orthopaedic surgeon Constance Chu has spent her career seeking ways to prevent osteoarthritis from developing after a knee injury.
On the importance of including pregnant women in clinical trials: A Q&A
A Stanford physician argues pregnant women should be appropriately included in clinical research to improve their health and the health of their fetuses.
Immunotherapy for peanut allergies: A Q&A
Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
Beating cancer’s wildfire while the flames rage
A novel immunotherapy appears safe for use in patients with non-Hodgkin’s lymphoma. Here, a Northern California man shares his experience in the study.
New hope for a drug to treat lymphedema symptoms
The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds